These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24076072)

  • 1. Sustained release of triamcinolone acetonide from an episcleral plaque of multilayered poly-ε-caprolactone matrix.
    Meng Y; Sun S; Li J; Nan K; Lan B; Jin Y; Chen H; Cheng L
    Acta Biomater; 2014 Jan; 10(1):126-33. PubMed ID: 24076072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Episcleral drug film for better-targeted ocular drug delivery and controlled release using multilayered poly-ε-caprolactone (PCL).
    Sun S; Li J; Li X; Lan B; Zhou S; Meng Y; Cheng L
    Acta Biomater; 2016 Jun; 37():143-54. PubMed ID: 27071973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.
    Li J; Lan B; Li X; Sun S; Lu P; Cheng L
    J Control Release; 2016 Dec; 243():78-85. PubMed ID: 27717742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
    Chen M; Li X; Liu J; Han Y; Cheng L
    J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.
    Robinson MR; Lee SS; Kim H; Kim S; Lutz RJ; Galban C; Bungay PM; Yuan P; Wang NS; Kim J; Csaky KG
    Exp Eye Res; 2006 Mar; 82(3):479-87. PubMed ID: 16168412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection.
    Inoue M; Takeda K; Morita K; Yamada M; Tanigawara Y; Oguchi Y
    Am J Ophthalmol; 2004 Dec; 138(6):1046-8. PubMed ID: 15629301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.
    Kadam RS; Tyagi P; Edelhauser HF; Kompella UB
    Int J Pharm; 2012 Sep; 434(1-2):140-7. PubMed ID: 22633904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release profile and transscleral permeation of triamcinolone acetonide loaded nanostructured lipid carriers (TA-NLC): in vitro and ex vivo studies.
    Araújo J; Garcia ML; Mallandrich M; Souto EB; Calpena AC
    Nanomedicine; 2012 Aug; 8(6):1034-41. PubMed ID: 22115598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of ocular pigmentation on transscleral delivery of triamcinolone acetonide.
    Du W; Sun S; Xu Y; Li J; Zhao C; Lan B; Chen H; Cheng L
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):633-8. PubMed ID: 23597073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel design of one-side coated biodegradable intrascleral implant for the sustained release of triamcinolone acetonide.
    Kim YM; Lim JO; Kim HK; Kim SY; Shin JP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):179-86. PubMed ID: 18667297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable scleral implants as new triamcinolone acetonide delivery systems.
    Felt-Baeyens O; Eperon S; Mora P; Limal D; Sagodira S; Breton P; Simonazzi B; Bossy-Nobs L; Guex-Crosier Y; Gurny R
    Int J Pharm; 2006 Sep; 322(1-2):6-12. PubMed ID: 16824708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable intrascleral implant of triamcinolone acetonide in experimental uveitis.
    Shin JP; Park YC; Oh JH; Lee JW; Kim YM; Lim JO; Kim SY
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):201-8. PubMed ID: 19456254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of biodegradable controlled release scleral systems of triamcinolone acetonide.
    Blatsios G; Tzimas AS; Mattheolabakis G; Panagi Z; Avgoustakis K; Gartaganis SP
    Curr Eye Res; 2010 Oct; 35(10):916-24. PubMed ID: 20858113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide.
    Wang C; Hou H; Nan K; Sailor MJ; Freeman WR; Cheng L
    Exp Eye Res; 2014 Dec; 129():74-82. PubMed ID: 25446320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of triamcinolone acetonide following intravitreal injection in New Zealand white rabbits.
    McGee DH; Dembinska O; Gruebbel MM
    Int J Toxicol; 2005; 24(6):419-25. PubMed ID: 16393934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal injection of triamcinolone acetonide into healthy rabbit eyes alters retinal function and morphology.
    Myers AC; Bruun A; Ghosh F; Adrian ML; Andréasson S; Ponjavic V
    Curr Eye Res; 2013 Jun; 38(6):649-61. PubMed ID: 23537282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release of triamcinolone from an episcleral micro film delivery system for open-globe eye injuries and proliferative vitreoretinopathy.
    Wu S; Bian C; Li X; Chen M; Yang J; Jin Y; Shen Y; Cheng L
    J Control Release; 2021 May; 333():76-90. PubMed ID: 33771623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved anti-inflammatory effects in rabbit eye model using biodegradable poly beta-amino ester nanoparticles of triamcinolone acetonide.
    Sabzevari A; Adibkia K; Hashemi H; De Geest BG; Mohsenzadeh N; Atyabi F; Ghahremani MH; Khoshayand MR; Dinarvand R
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5520-6. PubMed ID: 23833065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.
    Kim H; Robinson MR; Lizak MJ; Tansey G; Lutz RJ; Yuan P; Wang NS; Csaky KG
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2722-31. PubMed ID: 15277497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of intraocular drug delivery of Oregon green 488-labeled triamcinolone by subtenon injection using ocular fluorophotometry in rabbit eyes.
    Lee SJ; Kim ES; Geroski DH; McCarey BE; Edelhauser HF
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4506-14. PubMed ID: 18503001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.